key: cord-0845075-u17q19vx authors: Mansoor, Amtul; Chang, David; Mitra, Raman title: Rhythm, Conduction and ST elevation with COVID-19: Myocarditis or Myocardial Infarction? date: 2020-08-12 journal: HeartRhythm Case Rep DOI: 10.1016/j.hrcr.2020.08.001 sha: 74958fd512b972ddec774802acaa46f3724c53eb doc_id: 845075 cord_uid: u17q19vx nan This research did not receive any specific grant from funding agencies in the public, commercial, 26 or not-for-profit sectors . 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 J o u r n a l P r e -p r o o f expressed on the surface of alveolar and cardiac cells, which may account for the direct cardiac 48 involvement in COVID-19. 2 Myocarditis is an inflammatory disease caused by infectious and 49 non-infectious etiologies. 3 Fulminant myocarditis is the most severe type of myocarditis and is 50 predominantly caused by viral infections. It is characterized by a sudden and severe 51 inflammation of myocardium resulting in cardiogenic shock, ventricular tachyarrythmias or 52 bradyarrythmias, and can be fatal. 3 We describe a unique case in a critically ill patient with 53 COVID-19, revealing rapid electrocardiographic (ECG) changes and death within 24 hours 54 despite aggressive treatment. The patient started with a normal baseline ECG, which progressed 55 to marked PR prolongation with striking ST changes to a stable accelerated idioventricular 56 rhythm arising from the left ventricle, and finally to multiorgan system failure and pulseless 57 electrical activity. The differentiation of acute myocardial infarction from fulminant myocarditis 58 based on the ECG, clinical course, and laboratory abnormalities are discussed. 59 though Takotsubo cardiomyopathy was less likely. Due to concern for COVID-19-related 107 myocarditis, the patient was started on pulse-dose steroids and intravenous immunoglobulin 108 therapy, despite which, she became hypotensive with further elevation of lactate to 13.6 mmol/L 109 and troponin to 1696 ng/L, and pH reduced to 7.06. She expired within 12 hours from the onset 110 of ECG changes with pulseless electrical activity. 111 Potential Effects of Coronaviruses 179 on the Cardiovascular System: A Review COVID-19) SARS-CoV-2: a potential novel etiology of fulminant 185 myocarditis Electrocardiographic features in patients with acute 187 myocardial infarction associated with left main coronary artery occlusion Cardiovascular Considerations for Patients Health Care Workers, and Health Systems During the COVID-19 Pandemic Diagnostic and prognostic role of 193 electrocardiogram in acute myocarditis: A comprehensive review The Effect of Chloroquine Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection Association of Cardiac Injury With Mortality in Hospitalized 199 Patients With COVID-19 in Wuhan, China ST-segement elevation in Patients with 202 Covid-19 -A Case Series ST-Elevation Myocardial Infarction in 205 Patients With COVID-19: Clinical and Angiographic 206 Outcomes Leukoerythroblastic reaction in a patient with 210 COVID-19 infection It is important to recognize the cardiovascular complications among COVID-19 patients, including ischemia and conduction disease It is important to differentiate between fulminant myocarditis and myocardial infarction Due to risk of exposure to COVID-19, one must weigh the benefits and risks of pursuing an invasive strategy to diagnose and treat cardiac manifestations late in the course of advanced disease